216 related articles for article (PubMed ID: 29128795)
1. Chemosensitive effects of Astragaloside IV in osteosarcoma cells via induction of apoptosis and regulation of caspase-dependent Fas/FasL signaling.
Hu T; Fei Z; Wei N
Pharmacol Rep; 2017 Dec; 69(6):1159-1164. PubMed ID: 29128795
[TBL] [Abstract][Full Text] [Related]
2. Matrine induces caspase-dependent apoptosis in human osteosarcoma cells in vitro and in vivo through the upregulation of Bax and Fas/FasL and downregulation of Bcl-2.
Liang CZ; Zhang JK; Shi Z; Liu B; Shen CQ; Tao HM
Cancer Chemother Pharmacol; 2012 Feb; 69(2):317-31. PubMed ID: 21717192
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of Astragaloside IV for hair loss via inhibition of Fas/Fas L-mediated apoptotic signaling.
Kim MH; Kim SH; Yang WM
PLoS One; 2014; 9(3):e92984. PubMed ID: 24676213
[TBL] [Abstract][Full Text] [Related]
4. Astragaloside IV enhances taxol chemosensitivity of breast cancer via caveolin-1-targeting oxidant damage.
Zheng Y; Dai Y; Liu W; Wang N; Cai Y; Wang S; Zhang F; Liu P; Chen Q; Wang Z
J Cell Physiol; 2019 Apr; 234(4):4277-4290. PubMed ID: 30146689
[TBL] [Abstract][Full Text] [Related]
5. Astragaloside IV enhances cisplatin chemosensitivity in hepatocellular carcinoma by suppressing MRP2.
Qu X; Gao H; Zhai J; Sun J; Tao L; Zhang Y; Song Y; Hu T
Eur J Pharm Sci; 2020 May; 148():105325. PubMed ID: 32259679
[TBL] [Abstract][Full Text] [Related]
6. FR901228 induces tumor regression associated with induction of Fas ligand and activation of Fas signaling in human osteosarcoma cells.
Imai T; Adachi S; Nishijo K; Ohgushi M; Okada M; Yasumi T; Watanabe K; Nishikomori R; Nakayama T; Yonehara S; Toguchida J; Nakahata T
Oncogene; 2003 Dec; 22(58):9231-42. PubMed ID: 14647441
[TBL] [Abstract][Full Text] [Related]
7. The Fas/FasL Signaling Pathway: Its Role in the Metastatic Process and as a Target for Treating Osteosarcoma Lung Metastases.
Koshkina N; Yang Y; Kleinerman ES
Adv Exp Med Biol; 2020; 1258():177-187. PubMed ID: 32767242
[TBL] [Abstract][Full Text] [Related]
8. Astragaloside IV Induces Apoptosis, G
Su CM; Wang HC; Hsu FT; Lu CH; Lai CK; Chung JG; Kuo YC
In Vivo; 2020; 34(2):631-638. PubMed ID: 32111763
[TBL] [Abstract][Full Text] [Related]
9. Actein Inhibits Cell Proliferation and Migration in Human Osteosarcoma.
Chen Z; Wu J; Guo Q
Med Sci Monit; 2016 May; 22():1609-16. PubMed ID: 27173526
[TBL] [Abstract][Full Text] [Related]
10. The histone deacetylase inhibitor, MS-275 (entinostat), downregulates c-FLIP, sensitizes osteosarcoma cells to FasL, and induces the regression of osteosarcoma lung metastases.
Rao-Bindal K; Koshkina NV; Stewart J; Kleinerman ES
Curr Cancer Drug Targets; 2013 May; 13(4):411-22. PubMed ID: 23410027
[TBL] [Abstract][Full Text] [Related]
11. STAT3 inhibitor, cucurbitacin I, is a novel therapeutic agent for osteosarcoma.
Oi T; Asanuma K; Matsumine A; Matsubara T; Nakamura T; Iino T; Asanuma Y; Goto M; Okuno K; Kakimoto T; Yada Y; Sudo A
Int J Oncol; 2016 Dec; 49(6):2275-2284. PubMed ID: 27840900
[TBL] [Abstract][Full Text] [Related]
12. Cinobufagin Induces Apoptosis in Osteosarcoma Cells Via the Mitochondria-Mediated Apoptotic Pathway.
Dai G; Zheng D; Guo W; Yang J; Cheng AY
Cell Physiol Biochem; 2018; 46(3):1134-1147. PubMed ID: 29669353
[TBL] [Abstract][Full Text] [Related]
13. Astragaloside IV Enhances Cisplatin Chemosensitivity in Non-Small Cell Lung Cancer Cells Through Inhibition of B7-H3.
He CS; Liu YC; Xu ZP; Dai PC; Chen XW; Jin DH
Cell Physiol Biochem; 2016; 40(5):1221-1229. PubMed ID: 27960166
[TBL] [Abstract][Full Text] [Related]
14. Astragaloside IV alleviates ischemia reperfusion-induced apoptosis by inhibiting the activation of key factors in death receptor pathway and mitochondrial pathway.
Yin F; Zhou H; Fang Y; Li C; He Y; Yu L; Wan H; Yang J
J Ethnopharmacol; 2020 Feb; 248():112319. PubMed ID: 31639488
[TBL] [Abstract][Full Text] [Related]
15. Polydatin inhibits proliferation and promotes apoptosis of doxorubicin-resistant osteosarcoma through LncRNA TUG1 mediated suppression of Akt signaling.
Hu T; Fei Z; Su H; Xie R; Chen L
Toxicol Appl Pharmacol; 2019 May; 371():55-62. PubMed ID: 30974157
[TBL] [Abstract][Full Text] [Related]
16. Ursolic acid inhibits proliferation and induces apoptosis by inactivating Wnt/β-catenin signaling in human osteosarcoma cells.
Zhang RX; Li Y; Tian DD; Liu Y; Nian W; Zou X; Chen QZ; Zhou LY; Deng ZL; He BC
Int J Oncol; 2016 Nov; 49(5):1973-1982. PubMed ID: 27665868
[TBL] [Abstract][Full Text] [Related]
17. Astragaloside IV inhibits breast cancer cell invasion by suppressing Vav3 mediated Rac1/MAPK signaling.
Jiang K; Lu Q; Li Q; Ji Y; Chen W; Xue X
Int Immunopharmacol; 2017 Jan; 42():195-202. PubMed ID: 27930970
[TBL] [Abstract][Full Text] [Related]
18. Quantitative proteomics analysis of differentially expressed proteins induced by astragaloside IV in cervical cancer cell invasion.
Xia C; He Z; Cai Y
Cell Mol Biol Lett; 2020; 25():25. PubMed ID: 32265995
[TBL] [Abstract][Full Text] [Related]
19. Astragaloside IV sensitizes non-small cell lung cancer cells to gefitinib potentially via regulation of SIRT6.
Dai PC; Liu DL; Zhang L; Ye J; Wang Q; Zhang HW; Lin XH; Lai GX
Tumour Biol; 2017 Apr; 39(4):1010428317697555. PubMed ID: 28443459
[TBL] [Abstract][Full Text] [Related]
20. Antineoplastic effect of calycosin on osteosarcoma through inducing apoptosis showing in vitro and in vivo investigations.
Qiu R; Ma G; Zheng C; Qiu X; Li X; Li X; Mo J; Li Z; Liu Y; Mo L; Bi G; Ye Y
Exp Mol Pathol; 2014 Aug; 97(1):17-22. PubMed ID: 24797937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]